A previous study reported that the intravenous administration of progranulin reduces myocardial infarct size and improves left ventricular (LV) function through reducing the inflammation of the damaged heart in murine and rabbit models of acute myocardial infarction (AMI) [10]. This evidence concerns the gene GRN and acute myocardial infarction.